Stewart Factor

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Drug Dose-Response Relationship

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kay Denise M; Factor Stewart A; Samii Ali; Higgins Donald S; Griffith Alida; Roberts John W; Leis Berta C; Nutt John G; Montimurro Jennifer S; Keefe Robert G; Atkins April J; Yearout Dora; Zabetian Cyrus P; Payami Haydeh
Genetic association between alpha-synuclein and idiopathic Parkinson's disease.
Factor Stewart A
Current status of symptomatic medical therapy in Parkinson's disease.
McCulloch Colin C; Kay Denise M; Factor Stewart A; Samii Ali; Nutt John G; Higgins Donald S; Griffith Alida; Roberts John W; Leis Berta C; Montimurro Jennifer S; Zabetian Cyrus P; Payami Haydeh
Exploring gene-environment interactions in Parkinson's disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Stewart Factor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Kay Denise M; Factor Stewart A; Samii Ali; Higgins Donald S; Griffith Alida; Roberts John W; Leis Berta C; Nutt John G; Montimurro Jennifer S; Keefe Robert G; Atkins April J; Yearout Dora; Zabetian Cyrus P; Payami Haydeh
Genetic association between alpha-synuclein and idiopathic Parkinson's disease.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(7):1222-30.
2008: Factor Stewart A
Current status of symptomatic medical therapy in Parkinson's disease.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2008;5(2):164-80.
2008: McCulloch Colin C; Kay Denise M; Factor Stewart A; Samii Ali; Nutt John G; Higgins Donald S; Griffith Alida; Roberts John W; Leis Berta C; Montimurro Jennifer S; Zabetian Cyrus P; Payami Haydeh
Exploring gene-environment interactions in Parkinson's disease.
Human genetics 2008;123(3):257-65.
2008: Hutter Carolyn M; Samii Ali; Factor Stewart A; Nutt John G; Higgins Donald S; Bird Thomas D; Griffith Alida; Roberts John W; Leis Berta C; Montimurro Jennifer S; Kay Denise M; Edwards Karen L; Payami Haydeh; Zabetian Cyrus P
Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(2):134-9.
2008: Esper Christine D; Factor Stewart A
Failure of recognition of drug-induced parkinsonism in the elderly.
Movement disorders : official journal of the Movement Disorder Society 2008;23(3):401-4.
2008: Powers Karen M; Kay Denise M; Factor Stewart A; Zabetian Cyrus P; Higgins Donald S; Samii Ali; Nutt John G; Griffith Alida; Leis Berta; Roberts John W; Martinez Erica D; Montimurro Jennifer S; Checkoway Harvey; Payami Haydeh
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk.
Movement disorders : official journal of the Movement Disorder Society 2008;23(1):88-95.
2008: Factor Stewart A
The clinical spectrum of freezing of gait in atypical parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2008;23 Suppl 2():S431-8.
2007: Rosen Ami R; Steenland N Kyle; Hanfelt John; Factor Stewart A; Lah James J; Levey Allan I
Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history.
Neurogenetics 2007;8(4):263-70.
2007: Zabetian Cyrus P; Hutter Carolyn M; Factor Stewart A; Nutt John G; Higgins Donald S; Griffith Alida; Roberts John W; Leis Berta C; Kay Denise M; Yearout Dora; Montimurro Jennifer S; Edwards Karen L; Samii Ali; Payami Haydeh
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Annals of neurology 2007;62(2):137-44.
2007: Esper Christine D; Factor Stewart A
Current and future treatments in multiple system atrophy.
Current treatment options in neurology 2007;9(3):210-23.
2007: Kay Denise M; Moran Dawn; Moses Lina; Poorkaj Parvoneh; Zabetian Cyrus P; Nutt John; Factor Stewart A; Yu Chang-En; Montimurro Jennifer S; Keefe Robert G; Schellenberg Gerard D; Payami Haydeh
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.
Annals of neurology 2007;61(1):47-54.
2007: Esper Christine D; Weiner William J; Factor Stewart A
Progressive supranuclear palsy.
Reviews in neurological diseases 2007;4(4):209-16.
2006: Elbaz Alexis; Nelson Lorene M; Payami Haydeh; Ioannidis John P A; Fiske Brian K; Annesi Grazia; Carmine Belin Andrea; Factor Stewart A; Ferrarese Carlo; Hadjigeorgiou Georgios M; Higgins Donald S; Kawakami Hideshi; Krüger Rejko; Marder Karen S; Mayeux Richard P; Mellick George D; Nutt John G; Ritz Beate; Samii Ali; Tanner Caroline M; Van Broeckhoven Christine; Van Den Eeden Stephen K; Wirdefeldt Karin; Zabetian Cyrus P; Dehem Marie; Montimurro Jennifer S; Southwick Audrey; Myers Richard M; Trikalinos Thomas A
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.
Lancet neurology 2006;5(11):917-23.
2006: Zabetian Cyrus P; Hutter Carolyn M; Yearout Dora; Lopez Alexis N; Factor Stewart A; Griffith Alida; Leis Berta C; Bird Thomas D; Nutt John G; Higgins Donald S; Roberts John W; Kay Denise M; Edwards Karen L; Samii Ali; Payami Haydeh
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.
American journal of human genetics 2006;79(4):752-8.
2006: Kay Denise M; Zabetian Cyrus P; Factor Stewart A; Nutt John G; Samii Ali; Griffith Alida; Bird Tom D; Kramer Patricia; Higgins Donald S; Payami Haydeh
Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.
Movement disorders : official journal of the Movement Disorder Society 2006;21(4):519-23.
2006: Factor Stewart A; Higgins Donald S; Qian Jiang
Primary progressive freezing gait: a syndrome with many causes.
Neurology 2006;66(3):411-4.
2006: Kay Denise M; Bird Tom D; Zabetian Cyrus P; Factor Stewart A; Samii Ali; Higgins Donald S; Nutt John; Roberts John W; Griffith Alida; Leis Berta C; Montimurro Jennifer S; Philpott Sean; Payami Haydeh
Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease.
Genetic testing 2006;10(3):221-7.
2006: Huber Victor C; Mondal Tapan; Factor Stewart A; Seegal Richard F; Lawrence David A
Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression.
Journal of neuroinflammation 2006;3():1.
2005: Factor Stewart A; Molho Eric S; Evans Sharon; Feustel Paul J
Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1152-60.
2005: Factor Stewart A; Qian Jiang; Lava Neil S; Hubbard Jeffrey D; Payami Haydeh
False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy.
Annals of neurology 2005;57(3):462-3.
2004: Fernandez Hubert H; Friedman Joseph H; Lansang M Cecilia; Factor Stewart A; Molho Eric S; Coskun D Jim
Diabetes mellitus among parkinsonian patients treated chronically with clozapine.
Parkinsonism & related disorders 2004;10(7):439-41.
2004: Factor Stewart A; Molho Eric S
Threatening auditory hallucinations and Cotard syndrome in Parkinson disease.
Clinical neuropharmacology 2004;27(5):205-7.
2004: Factor Stewart A
Literature review: intermittent subcutaneous apomorphine therapy in Parkinson's disease.
Neurology 2004;62(6 Suppl 4):S12-7.
2003: Factor S A; Feustel P J; Friedman J H; Comella C L; Goetz C G; Kurlan R; Parsa M; Pfeiffer R;
Longitudinal outcome of Parkinson's disease patients with psychosis.
Neurology 2003;60(11):1756-61.
2002: Factor Stewart A; Jennings Danna L; Molho Eric S; Marek Kenneth L
The natural history of the syndrome of primary progressive freezing gait.
Archives of neurology 2002;59(11):1778-83.
2002: Reddy Sujana; Factor Stewart A; Molho Eric S; Feustel Paul J
The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
Movement disorders : official journal of the Movement Disorder Society 2002;17(4):676-81.
2002: Factor Stewart A
Pharmacology of atypical antipsychotics.
Clinical neuropharmacology 2002;25(3):153-7.
2002: Factor Stewart A; Molho Eric S; Friedman Joseph H
Risperidone and Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2002;17(1):221-2.
2002: Adler Charles H; Factor Stewart A; Brin Mitchell; Sethi Kapil D
Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
Movement disorders : official journal of the Movement Disorder Society 2002;17(1):158-61.
2001: Factor S A; Molho E S; Feustel P J; Brown D L; Evans S M
Long-term comparative experience with tolcapone and entacapone in advanced Parkinson's disease.
Clinical neuropharmacology 2001;24(5):295-9.
2001: Molho E S; Factor S A
Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.
Current neurology and neuroscience reports 2001;1(4):320-8.
2001: Lava N S; Factor S A
Focal myopathy as a cause of anterocollis in Parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):754-6.
2000: Factor S A; Lew M F; Trosch R M
Current and emerging treatments for cervical dystonia.
CNS spectrums 2000;5(6 Suppl 5):S1-8.
2000: Hauser R A; Friedlander J; Zesiewicz T A; Adler C H; Seeberger L C; O'Brien C F; Molho E S; Factor S A
A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia.
Clinical neuropharmacology 2000;23(2):75-81.
2000: Factor S A; Molho E S
Emergency department presentations of patients with Parkinson's disease.
The American journal of emergency medicine 2000;18(2):209-15.
2000: Factor S A; Brown D L; Molho E S
Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(1):167-9.
1999: Molho E S; Factor S A
Worsening of motor features of parkinsonism with olanzapine.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):1014-6.
1999: Brashear A; Lew M F; Dykstra D D; Comella C L; Factor S A; Rodnitzky R L; Trosch R; Singer C; Brin M F; Murray J J; Wallace J D; Willmer-Hulme A; Koller M
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
Neurology 1999;53(7):1439-46.
1999: Brin M F; Lew M F; Adler C H; Comella C L; Factor S A; Jankovic J; O'Brien C; Murray J J; Wallace J D; Willmer-Hulme A; Koller M
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
Neurology 1999;53(7):1431-8.
1999: Molho E S; Factor S A
Possible tardive dystonia resulting from clozapine therapy.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):873-4.
1999: Factor S A; Molho E S
Transient benefit of amantadine in Parkinson's disease: the facts about the myth.
Movement disorders : official journal of the Movement Disorder Society 1999;14(3):515-7.
1999: Factor S A
Dopamine agonists.
The Medical clinics of North America 1999;83(2):415-43, vi-vii.
1998: Kompoliti K; Goetz C G; Boeve B F; Maraganore D M; Ahlskog J E; Marsden C D; Bhatia K P; Greene P E; Przedborski S; Seal E C; Burns R S; Hauser R A; Gauger L L; Factor S A; Molho E S; Riley D E
Clinical presentation and pharmacological therapy in corticobasal degeneration.
Archives of neurology 1998;55(7):957-61.
1998: Molho E S; Feustel P J; Factor S A
Clinical comparison of tardive and idiopathic cervical dystonia.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):486-9.
1998: Factor S A; Molho E S; Brown D L
Acute delirium after withdrawal of amantadine in Parkinson's disease.
Neurology 1998;50(5):1456-8.
1997: Factor S A; Molho E S
Adult-onset tics associated with peripheral injury.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):1052-5.
1997: Factor S A; Barron K D
Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):783-9.
1997: Lew M F; Adornato B T; Duane D D; Dykstra D D; Factor S A; Massey J M; Brin M F; Jankovic J; Rodnitzky R L; Singer C; Swenson M R; Tarsy D; Murray J J; Koller M; Wallace J D
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
Neurology 1997;49(3):701-7.
1997: Factor S A; Friedman J H
The emerging role of clozapine in the treatment of movement disorders.
Movement disorders : official journal of the Movement Disorder Society 1997;12(4):483-96.
1997: Hauser R A; Zesiewicz T A; Factor S A; Guttman M; Weiner W J
Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness.
Parkinsonism & related disorders 1997;3(1):1-6.
1996: Podskalny G D; Factor S A
Chorea caused by lithium intoxication: a case report and literature review.
Movement disorders : official journal of the Movement Disorder Society 1996;11(6):733-7.
1996: Molho E S; Factor S A; Podskalny G D; Brown D
The effect of dancing on dystonia.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):225-7.
1995: Factor S A; Podskalny G D; Molho E S
Psychogenic movement disorders: frequency, clinical profile, and characteristics.
Journal of neurology, neurosurgery, and psychiatry 1995;59(4):406-12.
1995: Factor S A; Schneider A S
Peripheral catecholamine output in Parkinson's disease: effects of drug treatment.
Experimental neurology 1995;131(1):64-8.
1995: Molho E S; Factor S A; Weiner W J; Sanchez-Ramos J R; Singer C; Shulman L; Brown D; Sheldon C
The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.
Journal of neural transmission. Supplementum 1995;45():225-30.
1995: Factor S A; Molho E S; Podskalny G D; Brown D
Parkinson's disease: drug-induced psychiatric states.
Advances in neurology 1995;65():115-38.
1995: Factor S A; Molho E S; Brown D L
Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences 1995;7(3):304-7.
1994: Factor S A; Podskalny G D; Barron K D
Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report.
Journal of the neurological sciences 1994;127(1):114-20.
1994: Factor S A; Ortof E; Dentinger M P; Mankes R; Barron K D
Platelet morphology in Parkinson's disease: an electron microscopic study.
Journal of the neurological sciences 1994;122(1):84-9.
1994: Factor S A; Brown D; Molho E S; Podskalny G D
Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis.
Neurology 1994;44(3 Pt 1):544-6.
1993: Factor S A; Weiner W J
Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):257-62.
1993: Factor S A
Acetazolamide therapy of menstrual-related fluctuations in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1993;8(2):240-1.
1993: Molho E S; Factor S A
Basal ganglia infarction as a possible cause of cervical dystonia.
Movement disorders : official journal of the Movement Disorder Society 1993;8(2):213-6.
1993: Weiner W J; Factor S A; Sanchez-Ramos J R; Singer C; Sheldon C; Cornelius L; Ingenito A
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
Neurology 1993;43(1):21-7.
1992: Factor S A; Brown D
Clozapine prevents recurrence of psychosis in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(2):125-31.
1991: Factor S A; Coni R J; Cowger M; Rosenblum E L
Paroxysmal tremor and orofacial dyskinesia secondary to a biopterin synthesis defect.
Neurology 1991;41(6):930-2.
1991: Factor S A; Matthews M K
Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy.
Southern medical journal 1991;84(5):626-8.
1991: Tolge C F; Factor S A
Focal dystonia secondary to cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):69-72.
1991: Factor S A; Weiner W J
Prior history of head trauma in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1991;6(3):225-9.
1990: Factor S A; McAlarney T; Sanchez-Ramos J R; Weiner W J
Sleep disorders and sleep effect in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1990;5(4):280-5.
1990: Factor S A; Sanchez-Ramos J R; Weiner W J
Vitamin E therapy in Parkinson's disease.
Advances in neurology 1990;53():457-61.
1989: Factor S A; Weiner W J; Hefti F
Acetaminophen metabolism by cytochrome P450 monooxygenases in Parkinson's disease.
Annals of neurology 1989;26(2):286-8.
1989: Weiner W J; Factor S A; Sanchez-Ramos J R
The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(6):732-5.
1989: Factor S A; Sanchez-Ramos J R; Weiner W J; Ingenito A M
Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(1):83-8.
1989: Sanchez-Ramos J R; Factor S A; Weiner W J; Marquez J
Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis.
Movement disorders : official journal of the Movement Disorder Society 1989;4(3):266-73.
1988: Factor S A; Sanchez-Ramos J R; Weiner W J
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.
Journal of neurology, neurosurgery, and psychiatry 1988;51(4):529-33.
1988: Factor S A; Sanchez-Ramos J R; Weiner W J
Cocaine and Tourette's syndrome.
Annals of neurology 1988;23(4):423-4.
1988: Factor S A; Sanchez-Ramos J; Weiner W J
Delayed-onset dystonia associated with corticospinal tract dysfunction.
Movement disorders : official journal of the Movement Disorder Society 1988;3(3):201-10.
1988: Factor S A; Sanchez-Ramos J; Weiner W J
Trauma as an etiology of parkinsonism: a historical review of the concept.
Movement disorders : official journal of the Movement Disorder Society 1988;3(1):30-6.
1987: Factor S A; Dentinger M P
Early brain-stem auditory evoked responses in vertebrobasilar transient ischemic attacks.
Archives of neurology 1987;44(5):544-7.
1987: Weiner W J; Factor S A; Sanchez-Ramos J; Berger J
A double-blind evaluation of ciladopa in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1987;2(3):211-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Stewart Factor

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Stewart Factor (preview)

All Publications